Amphastar Pharmaceuticals CEO Jack Zhang's 2021 pay rises 9% to $6.5M
Amphastar Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 14, 2022
Amphastar Pharmaceuticals reported fiscal year 2021 executive compensation information on April 14, 2022.
In 2021, five executives at Amphastar Pharmaceuticals received on average a compensation package of $3.1M, a 10% decrease compared to previous year.
Average pay of disclosed executives at Amphastar Pharmaceuticals
Jack Yongfeng Zhang, Chief Executive Officer, received $6.5M in total, which increased by 9% compared to 2020. 35% of Zhang's compensation, or $2.3M, was in option awards. Zhang also received $311K in bonus, $673K in non-equity incentive plan, $898K in salary, $2.3M in stock awards, as well as $51K in other compensation.
For fiscal year 2021, the median employee pay was $54,552 at Amphastar Pharmaceuticals. Therefore, the ratio of Jack Yongfeng Zhang's pay to the median employee pay was 119 to one.
Mary Ziping Luo, Chief Operating Officer, received a compensation package of $3.4M, which increased by 13% compared to previous year. 30% of the compensation package, or $1M, was in option awards.
William J. Peters, Chief Financial Officer, earned $2.4M in 2021, a 14% increase compared to previous year.
Rong Zhou, Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc, received $1.6M in 2021, which increases by 12% compared to 2020.
Jacob Liawatidewi, Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S, earned $1.5M in 2021, a 8% increase compared to previous year.
Related executives
Jack Zhang
Amphastar Pharmaceuticals
Chief Executive Officer
William Peters
Amphastar Pharmaceuticals
Chief Financial Officer
Mary Luo
Amphastar Pharmaceuticals
Chief Operating Officer
Rong Zhou
Amphastar Pharmaceuticals
Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc
Jacob Liawatidewi
Amphastar Pharmaceuticals
Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S
You may also like
Source: SEC filing on April 14, 2022.